Schedule: Daily subcutaneous injections for 812 weeks (extend to 16 weeks if desired)
That makes the evidence promising, but not yet conclusive
I conducted hours of my own education and due diligence in the areas of preventive health and regenerative therapies regarding vitality and organ functionality." Craig "Thank you so much for making me look so beautiful
Prog Chem
studied whether young people and old people would act differently while undertaking IF (17), Paoli et al
However, some secondary measures of nerve impairment did improve, especially in participants with higher cardiovascular risk and moderate BMI.7 Shorter-term trials have shown that 600mg/day of oral racemic ALA reduced neuropathy symptoms like burning, tingling, and numbness in as little as 35 weeks.4 20 A 2010 meta-analysis concluded that oral ALA can improve symptoms of diabetic neuropathy, but noted variability in effect sizes across trials and better results with intravenous administration.1 Despite promising results from some trials, a recent systematic review evaluating eight randomized controlled trials indicates that findings on ALA's effectiveness in treating diabetic neuropathy symptoms are inconsistent.23 While ALA proved safe and tolerable across these studies, the review concluded that definitive evidence supporting significant benefits is limited